Loading stock data…
G
$32.63+0.23 (+0.71%)
After Hours$32.63+0.00 (+0.00%)· Last close Jun 9
Genpact Limited provides business process outsourcing and information technology services in India, the rest of Asia, North and Latin America, and Europe.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Genpact Limited in the Technology sector is trading at $32.63 with a market capitalization of $5.5B. Wall Street consensus targets $42.45 (11 analysts), implying a +30.1% move over the next 12 months. The stock is currently near its 52-week low of $28.78, remaining 18.9% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +30.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
AAPLMSFTGOOGL
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$32.63
Potential Upside
73.2%
Whystock Fair Value$56.52
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus11 analysts
Buy
Mean target$42.45+30.1%
Range$32.00 – $58.00
Fundamentals
Genpact Limited provides business process outsourcing and information technology services in India, the rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.48B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
9.91
Beta
Defensive asset. Lower volatility than the S&P 500.
0.62
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.10%
ROE
Elite ROE. Management converts capital into profit efficiently.
23.01%
Volume
Today's trading volume
1.67M
Recent News
1 Value Stock to Keep an Eye On and 2 We Ignore
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason — five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
1 Small-Cap Stock with Competitive Advantages and 2 We Ignore
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Assessing Genpact (G) Valuation After A Weak Year Of Share Price Performance
Genpact stock performance snapshot Genpact (G) stock has fallen 4.1% over the past month and 18.98% over the past 3 months, leaving it down 28.03% year to date and 21.41% over the past year. See our latest analysis for Genpact. The recent 1-day share price return decline of 4.09% to US$33.04 comes after a 7-day share price gain of 5.93%. However, both the 1-year total shareholder return decline of 21.41% and the 5-year total shareholder return decline of 22.82% point to fading momentum...
Reasons Why You Should Retain Genpact Stock in Your Portfolio
G rides on AI, agentic operations and large deal wins as its ATS segment grows rapidly. Its talent costs and slower-growth dynamics remain concerns.
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Question
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.